Ms Irene Young (Hong Kong, China)

Australie

12 INTELLECTUAL PROPERTY AND THE PUBLIC INTEREST: REGULATORY REVIEW EXEPTION

416. Australia notes the communication from the Plurinational State of Bolivia, Brazil, Chile and South Africa regarding Intellectual Property and the Public Interest Regulatory Review Exception. 417. Australia's Patents Act provides infringement exemptions for the purpose of obtaining regulatory approval of pharmaceuticals (sl 19A). 418. This permits generic manufacturers to obtain regulatory approval during the term of the pharmaceutical patent so they can enter the market when the patent term expires. 419. We look forward to hearing other Members' examples.

The Council took note of the statements made.

36. The Chairperson said that this item had been put on the agenda at the request of the Plurinational State of Bolivia, Brazil, Chile and South Africa. A relevant communication from the co-sponsors had been circulated in document IP/C/W/639.

37. The representatives of Brazil, South Africa, El Salvador, Costa Rica, Chile, Singapore, Canada, China, Australia, Argentina, India, Indonesia, Switzerland, the United States, Chinese Taipei, Japan, and the European Union took the floor.

38. The Council took note of the statements made.

IP/C/M/88, IP/C/M/88/Add.1